{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T01:28:42Z","timestamp":1755221322056,"version":"3.43.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.semnephrol.2025.151653","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T23:23:35Z","timestamp":1752621815000},"page":"151653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["How to Suspect and Approach Patients With Genetic Glomerular Disease"],"prefix":"10.1016","volume":"45","author":[{"given":"Janewit","family":"Wongboonsin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asheeta","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Quinlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5 Pt 1","key":"10.1016\/j.semnephrol.2025.151653_bib0001","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0022-3476(79)80710-6","article-title":"Microscopic hematuria in school children: epidemiology and clinicopathologic evaluation","volume":"95","author":"Vehaskari","year":"1979","journal-title":"J Pediatr"},{"issue":"4S","key":"10.1016\/j.semnephrol.2025.151653_bib0002","first-page":"S1","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases","volume":"100","year":"2021","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151653_bib0003","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.2215\/CJN.11440919","article-title":"Genetic disorders of the glomerular filtration barrier","volume":"15","author":"Li","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.semnephrol.2025.151653_bib0004","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1007\/s00467-022-05846-1","article-title":"Clinical and diagnostic utility of genomic sequencing for children referred to a Kidney Genomics Clinic with microscopic haematuria","volume":"38","author":"Shanks","year":"2023","journal-title":"Pediatr Nephrol Berl Ger"},{"key":"10.1016\/j.semnephrol.2025.151653_bib0005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.humpath.2018.02.024","article-title":"A unique evolution of the kidney phenotype in a patient with autosomal recessive Alport syndrome","volume":"81","author":"Vischini","year":"2018","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151653_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2023.100631","article-title":"Alport syndrome: clinical spectrum and therapeutic advances","volume":"5","author":"Gregorio","year":"2023","journal-title":"Kidney Med"},{"issue":"10","key":"10.1016\/j.semnephrol.2025.151653_bib0007","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.ekir.2023.07.010","article-title":"The phenotypic spectrum of COL4A3 heterozygotes","volume":"8","author":"Solanki","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151653_bib0008","first-page":"183","article-title":"Clinical impact of genomic testing in patients with suspected monogenic kidney disease","volume":"23","author":"Jayasinghe","year":"2021","journal-title":"Genet Med Off J Am Coll Med Genet"},{"issue":"7","key":"10.1016\/j.semnephrol.2025.151653_bib0009","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1056\/NEJMra2308577","article-title":"Genetics of chronic kidney disease","volume":"391","author":"Vivante","year":"2024","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.semnephrol.2025.151653_bib0010","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1093\/hmg\/ddt560","article-title":"Allelic heterogeneity contributes to variability in ocular dysgenesis, myopathy and brain malformations caused by Col4a1 and Col4a2 mutations","volume":"23","author":"Kuo","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151653_bib0011","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12929-023-00959-7","article-title":"Phenotypic heterogeneity in human genetic diseases: ultrasensitivity-mediated threshold effects as a unifying molecular mechanism","volume":"30","author":"Sun","year":"2023","journal-title":"J Biomed Sci"},{"issue":"8","key":"10.1016\/j.semnephrol.2025.151653_bib0012","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1016\/j.ekir.2024.05.007","article-title":"Renal and extrarenal phenotypes in patients with HNF1B variants and chromosome 17q12 microdeletions","volume":"9","author":"Buffin-Meyer","year":"2024","journal-title":"Kidney Int Rep"},{"issue":"8","key":"10.1016\/j.semnephrol.2025.151653_bib0013","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1681\/ASN.2020050558","article-title":"AKI and collapsing glomerulopathy associated with COVID-19 and APOL 1 high-risk genotype","volume":"31","author":"Wu","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2025.151653_bib0014","doi-asserted-by":"crossref","first-page":"110","DOI":"10.5414\/CNCS111112","article-title":"Successful treatment of COVID-19-associated collapsing glomerulopathy: 22 months of follow-up","volume":"11","author":"Gandhi","year":"2023","journal-title":"Clin Nephrol Case Stud"},{"key":"10.1016\/j.semnephrol.2025.151653_bib0015","article-title":"Novel INF2 mutations in an Italian cohort of patients with focal segmental glomerulosclerosis, renal failure and Charcot-Marie-Tooth neuropathy","volume":"29","author":"Caridi","year":"2014","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc \u2013 Eur Ren Assoc"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151653_bib0016","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.kint.2021.08.014","article-title":"Contactin-1 is a novel target antigen in membranous nephropathy associated with chronic inflammatory demyelinating polyneuropathy","volume":"100","author":"Le Quintrec","year":"2021","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.semnephrol.2025.151653_bib0017","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/humu.24309","article-title":"Variant interpretation using population databases: lessons from gnomAD","volume":"43","author":"Gudmundsson","year":"2022","journal-title":"Hum Mutat"},{"issue":"8","key":"10.1016\/j.semnephrol.2025.151653_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070151","article-title":"Filtering for compound heterozygous sequence variants in non-consanguineous pedigrees","volume":"8","author":"Kamphans","year":"2013","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151653_bib0019","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.kint.2022.03.019","article-title":"Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"101","year":"2022","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.semnephrol.2025.151653_bib0020","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1681\/ASN.0000000000000401","article-title":"The role of genetic testing in adult CKD","volume":"35","author":"Knoers","year":"2024","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151653_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2022.100435","article-title":"Emerging role of clinical genetics in CKD","volume":"4","author":"Devarajan","year":"2022","journal-title":"Kidney Med"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151653_bib0022","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1182\/bloodadvances.2020003175","article-title":"Outcomes of a clinician-directed protocol for discontinuation of complement inhibition therapy in atypical hemolytic uremic syndrome","volume":"5","author":"Chaturvedi","year":"2021","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151653_bib0023","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ekir.2022.10.013","article-title":"Early eculizumab withdrawal in patients with atypical hemolytic uremic syndrome in native kidneys is safe and cost-effective: results of the CUREiHUS study","volume":"8","author":"Bouwmeester","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151653_bib0024","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00467-023-06134-2","article-title":"Copy number variation analysis in 138 families with steroid-resistant nephrotic syndrome identifies causal homozygous deletions in PLCE1 and NPHS2 in two families","volume":"39","author":"Pantel","year":"2024","journal-title":"Pediatr Nephrol Berl Ger"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151653_bib0025","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.ajkd.2021.02.326","article-title":"Clinical and genetic features of autosomal dominant Alport syndrome: a cohort study","volume":"78","author":"Furlano","year":"2021","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151653_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2024.100826","article-title":"A review of focal segmental glomerulosclerosis classification with a focus on genetic associations","volume":"6","author":"Bonilla","year":"2024","journal-title":"Kidney Med"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151653_bib0027","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000504869","article-title":"Utility of genomic testing after renal biopsy","volume":"51","author":"Murray","year":"2020","journal-title":"Am J Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151653_bib0028","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1681\/ASN.2017090958","article-title":"Differentiating primary, genetic, and secondary FSGS in adults: a clinicopathologic approach","volume":"29","author":"De Vriese","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151653_bib0029","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1681\/ASN.2015040385","article-title":"High-throughput genetic testing for thrombotic microangiopathies and C3 glomerulopathies","volume":"27","author":"Bu","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.semnephrol.2025.151653_bib0030","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.2215\/CJN.0000000000000252","article-title":"Rare variants in complement gene in C3 glomerulopathy and immunoglobulin-mediated membranoproliferative GN","volume":"18","author":"Meuleman","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151653_bib0031","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1681\/ASN.2015060612","article-title":"Mayo Clinic\/Renal Pathology Society consensus report on pathologic classification, diagnosis, and reporting of GN","volume":"27","author":"Sethi","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151653_bib0032","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.kint.2024.05.015","article-title":"The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"106","author":"Vivarelli","year":"2024","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151653_bib0033","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41581-020-0329-y","article-title":"Complexities of the glomerular basement membrane","volume":"17","author":"Naylor","year":"2021","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151653_bib0034","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.humpath.2005.12.017","article-title":"Hereditary nephritis mimicking immune complex-mediated glomerulonephritis","volume":"37","author":"Nasr","year":"2006","journal-title":"Hum Pathol"},{"key":"10.1016\/j.semnephrol.2025.151653_bib0035","article-title":"Thrombotic microangiopathy in the renal allograft: results of the TMA Banff Working Group consensus on pathologic diagnostic criteria","volume":"36","author":"Afrouzian","year":"2023","journal-title":"Transpl Int Off J Eur Soc Organ Transplant"},{"issue":"9","key":"10.1016\/j.semnephrol.2025.151653_bib0036","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.mayocp.2021.01.037","article-title":"Identification of genetic causes of focal segmental glomerulosclerosis increases with proper patient selection","volume":"96","author":"Miao","year":"2021","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151653_bib0037","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1053\/j.ajkd.2022.06.012","article-title":"Adult-onset focal segmental glomerulosclerosis with steroid-dependent nephrotic syndrome caused by a novel TBC1D8B variant: a case report and literature review","volume":"81","author":"Fang","year":"2023","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"issue":"11","key":"10.1016\/j.semnephrol.2025.151653_bib0038","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1007\/s00467-018-4093-1","article-title":"Treatment of steroid-resistant nephrotic syndrome in the genomic era","volume":"34","author":"Bensimhon","year":"2019","journal-title":"Pediatr Nephrol Berl Ger"},{"issue":"7","key":"10.1016\/j.semnephrol.2025.151653_bib0039","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00467-010-1468-3","article-title":"Successful treatment of steroid-resistant nephrotic syndrome associated with WT1 mutations","volume":"25","author":"Gellermann","year":"2010","journal-title":"Pediatr Nephrol Berl Ger"},{"issue":"8","key":"10.1016\/j.semnephrol.2025.151653_bib0040","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41581-021-00424-4","article-title":"Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics","volume":"17","author":"Fakhouri","year":"2021","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151653_bib0041","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/cei.12890","article-title":"Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders","volume":"187","author":"Wehling","year":"2017","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151653_bib0042","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00862594","article-title":"Complement profiles in acute post-streptococcal glomerulonephritis","volume":"2","author":"Wyatt","year":"1988","journal-title":"Pediatr Nephrol Berl Ger"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151653_bib0043","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1681\/ASN.2019080851","article-title":"Anti-factor B antibodies and acute postinfectious GN in children","volume":"31","author":"Chauvet","year":"2020","journal-title":"J Am Soc Nephrol JASN"},{"issue":"7265","key":"10.1016\/j.semnephrol.2025.151653_bib0044","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nature08494","article-title":"Finding the missing heritability of complex diseases","volume":"461","author":"Manolio","year":"2009","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.semnephrol.2025.151653_bib0045","doi-asserted-by":"crossref","DOI":"10.1172\/JCI181467","article-title":"Quantifying variant contributions in cystic kidney disease using national-scale whole-genome sequencing","volume":"134","author":"Sadeghi-Alavijeh","year":"2024","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151653_bib0046","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s44162-024-00036-z","article-title":"Explaining Alport syndrome-lessons from the adult nephrology clinic","volume":"3","author":"Mabillard","year":"2024","journal-title":"J Rare Dis Berl Ger"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151653_bib0047","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1681\/ASN.2012100985","article-title":"COL4A3\/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome","volume":"24","author":"Storey","year":"2013","journal-title":"J Am Soc Nephrol JASN"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151653_bib0048","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3390\/jcm8020178","article-title":"Features of autosomal recessive Alport syndrome: a systematic review","volume":"8","author":"Lee","year":"2019","journal-title":"J Clin Med"},{"issue":"9","key":"10.1016\/j.semnephrol.2025.151653_bib0049","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1681\/ASN.2020071065","article-title":"Prevalence estimates of predicted pathogenic COL4A3-COL4A5 variants in a population sequencing database and their implications for Alport syndrome","volume":"32","author":"Gibson","year":"2021","journal-title":"J Am Soc Nephrol JASN"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151653_bib0050","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000458710","article-title":"Female patient with Alport syndrome and concomitant membranous nephropathy: susceptibility or association of two diseases?","volume":"136","author":"Veloso","year":"2017","journal-title":"Nephron"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151653_bib0051","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41431-023-01291-2","article-title":"Reanalysis of clinical exome identifies the second variant in two individuals with recessive disorders","volume":"31","author":"Li","year":"2023","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151653_bib0052","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/MNH.0000000000000983","article-title":"Alport syndrome and Alport kidney diseases: elucidating the disease spectrum","volume":"33","author":"Puapatanakul","year":"2024","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151653_bib0053","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12882-023-03165-7","article-title":"Alport syndrome misdiagnosed with IgA nephropathy from familial history: a case report and brief review","volume":"24","author":"Rahimzadeh","year":"2023","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.semnephrol.2025.151653_bib0054","doi-asserted-by":"crossref","unstructured":"Kiryluk K, Sanchez-Rodriguez E, Zhou X-j., et al. GWAS defines pathogenic signaling pathways and prioritizes drug targets for IgA nephropathy. medRxiv. Published online January 1, 2021. doi:10.1101\/2021.11.19.21265383","DOI":"10.1101\/2021.11.19.21265383"},{"issue":"1\u20132","key":"10.1016\/j.semnephrol.2025.151653_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ahg.12481","article-title":"Segregation analysis identifies specific alpha-defensin (DEFA1A3) SNP-CNV haplotypes in predisposition to IgA nephropathy","volume":"87","author":"Shwan","year":"2023","journal-title":"Ann Hum Genet"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151653_bib0056","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.semnephrol.2018.05.015","article-title":"Genetic determinants of IgA nephropathy: Eastern perspective","volume":"38","author":"Li","year":"2018","journal-title":"Semin Nephrol"},{"issue":"10","key":"10.1016\/j.semnephrol.2025.151653_bib0057","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1681\/ASN.2010010076","article-title":"HLA has strongest association with IgA nephropathy in genome-wide analysis","volume":"21","author":"Feehally","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151653_bib0058","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1186\/s12882-021-02567-9","article-title":"Tale of two nephropathies; co-occurring Alport syndrome and IgA nephropathy, a case report","volume":"22","author":"Bhattacharyya","year":"2021","journal-title":"BMC Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151653_bib0059","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1053\/j.ajkd.2021.04.017","article-title":"Pathogenic variants in the genes affected in Alport syndrome (COL4A3-COL4A5) and their association with other kidney conditions: a review","volume":"78","author":"Savige","year":"2021","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151653_bib0060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2215\/CJN.04230321","article-title":"Guidelines for genetic testing and management of Alport syndrome","volume":"17","author":"Savige","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5993","key":"10.1016\/j.semnephrol.2025.151653_bib0061","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151653_bib0062","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2215\/CJN.15161219","article-title":"APOL1 nephropathy: from genetics to clinical applications","volume":"16","author":"Friedman","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2025.151653_bib0063","article-title":"Challenging the narrative of Alport syndrome spectrum: no link with cystic phenotype","author":"Pagniez","year":"2024","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc \u2013 Eur Ren Assoc"},{"issue":"8","key":"10.1016\/j.semnephrol.2025.151653_bib0064","first-page":"1288","article-title":"Cystic phenotype and chronic kidney disease in autosomal dominant Alport syndrome","volume":"39","author":"Bada-Bosch","year":"2024","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc \u2013 Eur Ren Assoc"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151653_bib0065","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/jpc.16514","article-title":"A decision-making framework for genomic testing in paediatric nephrology","volume":"59","author":"Beadell","year":"2023","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.semnephrol.2025.151653_bib0066","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1201712","article-title":"What patients want to know about genetic testing for kidney disease","volume":"10","author":"Savige","year":"2023","journal-title":"Front Med"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151653_bib0067","first-page":"11","article-title":"From genetics to genomics: facing the liability implications in clinical care","volume":"48","author":"Marchant","year":"2020","journal-title":"J Law Med Ethics J Am Soc Law Med Ethics"},{"issue":"11","key":"10.1016\/j.semnephrol.2025.151653_bib0068","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1681\/ASN.0000000000000219","article-title":"Genetic inhibition of APOL1 pore-forming function prevents APOL1-mediated kidney disease","volume":"34","author":"Hung","year":"2023","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151653_bib0069","doi-asserted-by":"crossref","first-page":"7836","DOI":"10.1038\/s41467-023-43020-9","article-title":"Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease","volume":"14","author":"Gupta","year":"2023","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151653_bib0070","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa2404211","article-title":"apol1 bi- and monoallelic variants and chronic kidney disease in West Africans","volume":"392","author":"Gbadegesin","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2025.151653_bib0071","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7076326","article-title":"Prevalence of APOL1 risk variants in Afro-descendant patients with chronic kidney disease in a Latin American country","author":"Duran","year":"2019","journal-title":"Int J Nephrol."},{"key":"10.1016\/j.semnephrol.2025.151653_bib0072","article-title":"Multiethnic prevalence of the APOL1 G1 and G2 variants among the israeli dialysis population","author":"Ben-Ruby","year":"2024","journal-title":"Clin Kidney J"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151653_bib0073","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.kint.2023.11.028","article-title":"Idiopathic collapsing glomerulopathy is associated with APOL1 high-risk genotypes or Mendelian variants in most affected individuals in a highly admixed population","volume":"105","author":"Neves","year":"2024","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151653_bib0074","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1681\/ASN.0000000000000076","article-title":"A clinical workflow for cost-saving high-rate diagnosis of genetic kidney diseases","volume":"34","author":"Becherucci","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2025.151653_bib0075","article-title":"Utility of genetic testing in adults with chronic kidney disease: a systematic review and meta-analysis","author":"Schott","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151653_bib0076","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1681\/ASN.0000000000000249","article-title":"The clinical utility of genetic testing in the diagnosis and management of adults with chronic kidney disease","volume":"34","author":"Dahl","year":"2023","journal-title":"J Am Soc Nephrol JASN"},{"key":"10.1016\/j.semnephrol.2025.151653_bib0077","unstructured":"Glucocorticoid-remediable aldosteronism: clinical genetic test\u2013GTR\u2013NCBI. Accessed January 29, 2025. https:\/\/www.ncbi.nlm.nih.gov\/gtr\/tests\/265063\/"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151653_bib0078","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1002\/cphg.92","article-title":"Encoding clinical data with the human phenotype ontology for computational differential diagnostics","volume":"103","author":"K\u00f6hler","year":"2019","journal-title":"Curr Protoc Hum Genet"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151653_bib0079","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12882-020-02007-0","article-title":"Immune-complex glomerulonephritis with a membranoproliferative pattern in Frasier syndrome: a case report and review of the literature","volume":"21","author":"Matsuoka","year":"2020","journal-title":"BMC Nephrol"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929525000919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929525000919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T14:44:33Z","timestamp":1754664273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929525000919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":79,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0270929525000919"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2025.151653","relation":{},"ISSN":["0270-9295"],"issn-type":[{"type":"print","value":"0270-9295"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How to Suspect and Approach Patients With Genetic Glomerular Disease","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2025.151653","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"151653"}}